Lymphocyte subsets, TNFα and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients

Journal of Neuroimmunology

Volumn 163, Issue 1-2, 2005, Pages 195-198

  Anlar, Banu ^a   Guven, Alev ^b   Köse, Gulsen ^b   Okur, Hamza ^a   Kose, Ozgü ^a   Aydin, Omer F ^c   Kabakus, Nimet ^d   Altunbasak, Sakir ^e   Herguner, Ozlem ^e   Sonmez, Mujgan ^f   Serdaroglu, Ayse ^g  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Social Security Hospital   (Turkey)

^c DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^d FIRAT UNIVERSITY   (Turkey)

^e CUKUROVA UNIVERSITY   (Turkey)

^f KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^g GAZI UNIVERSITY   (Turkey)

Author keywords

Flow cytometry; Immunity; Lymphocyte; Subacute sclerosing panencephalitis

Indexed keywords

ALPHA INTERFERON; ANTICONVULSIVE AGENT; BETA INTERFERON; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 4; METHISOPRINOL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; HUMAN; LYMPHOCYTE SUBPOPULATION; NEUROPATHOLOGY; PRIORITY JOURNAL; SUBACUTE SCLEROSING PANENCEPHALITIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INOSINE PRANOBEX; INTERFERONS; INTERLEUKIN-4; LYMPHOCYTE SUBSETS; MALE; SUBACUTE SCLEROSING PANENCEPHALITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21044457802     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.02.014     Document Type: Article

References (18)

1. B. Anlar, K. Yalaz, T. Imir, and G. Turanli The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study Eur. Neurol. 34 1994 44 47
2. B. Anlar, F. Soylemezoglu, S. Aysun, G. Kose, D. Belen, and K. Yalaz Tissue inflammatory response in subacute sclerosing panencephalitis (SSPE) J. Child Neurol. 16 2001 895 900
3. S. Aysun, O. Sanal, Y. Renda, A.I. Berkel, K. Yalaz, F. Ersoy, and E. Ozdirim Cell mediated immunity in patients with subacute sclerosing panencephalitis Brain Develop. 6 1984 391 396
4. H. Bolay, R. Karabudak, C. Aybay, H. Candemir, K. Varli, T. Imir, and E. Kansu Alpha interferon treatment in myasthenia gravis: effects on natural killer cell activity J. Neuroimmunol. 82 1998 109 115
5. A. Czlonkowska, M. Poltorak, M. Vainiene, M. Czachorowska, and J. Korlak Subacute sclerosing panencephalitis and progressive multiple sclerosis: T cell subsets in blood and CSF Neurology 36 1986 992 993
6. S.S. Dhib-Jalbut, A.M. Abdelnoor, and F.S. Haddad Cellular and humoral immunity in subacute sclerosing panencephalitis Infect. Immun. 33 1981 34 42
7. D. Finke, U.G. Brinckmann, V. ter Meulen, and U.G. Liebert Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis J. Virol. 69 1995 5469 5474
8. J.M. Gata, J.M. Garcia-Moreno, L. Dinca, V. Sanchez-Margalet, G. Navarro, and G. Izquierdo Changes in lymphocyte subsets and treatment with beta interferon in active multiple sclerosis Rev. Neurol. 27 1988 939 942
9. S. Haspolat, B. Anlar, G. Kose, M. Coskun, and O. Yegin Interleukin-1beta, interleukin-1 receptor antagonist levels in patients with subacute sclerosing panencephalitis and the effects of different treatment protocols J. Child Neurol. 16 2001 417 420
10. A. Ikinciogullari, T. Kendirli, F. Dogu, Y. Egin, I. Reisli, S. Cin, and E. Babacan Peripheral blood lymphocyte subsets in healthy Turkish children Turk. J. Pediatr. 46 2004 125 130
11. T. Inoue, R. Kira, F. Nakao, K. Ihara, W.M. Bassuny, K. Kasuhara, K. Nihei, K. Takeshita, and T. Hara Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis Arch. Neurol. 59 2002 822 827
12. M. Khademi, E. Wallstrom, M. Andersson, F. Piehl, R. Di Marco, and T. Olsson Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis J. Neuroimmunol. 103 2000 202 210
13. M.G. Marrosu, C. Cianchetti, and M.G. Ennas Lymphocyte subsets at different stages of subacute sclerosing panencephalitis: a study with monoclonal antibodies J. Neurol. Neurosurg. Psychiatry 49 1986 713 715
14. L.M. Ossege, E. Sindern, T. Patzold, and J.P. Malin Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type II J. Neuroimmunol. 91 1998 73 81
15. L.M. Ossege, E. Sindern, T. Patzold, and J.P. Malin Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis Int. Immunopharmacol. 1 2001 1085 1100
16. O. Sanal, M. Basaran, S. Aysun, O. Yegin, and A.I. Berkel Subpopulations of T lymphocytes in subacute sclerosing panencephalitis (SSPE) Turk. J. Pediatr. 28 1986 23 29
17. H. Tekgul, S. Tutuncuoglu, N. Kutukculer, G. Dizdarer, and A. Huseyinov Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis J. Child Neurol. 14 1999 418 421
18. K. Yalaz, B. Anlar, F. Oktem, S. Aysun, S. Ustacelebi, O. Gurcay, K. Gucuyener, and Y. Renda Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis Neurology 42 1992 488 491